Pfizer, a global biopharmaceutical company headquartered in New York City, employs 88,000 people and focuses on discovering, developing, and distributing oncology, primary care, and specialty care products worldwide. Key products include Ibrance, Eliquis, and Xeljanz, among others.
PFE has been in the news recently: Nona Biosciences announced Pfizer's preclinical data on PF-08052666, a novel antibody-drug conjugate, which demonstrated strong potential for cancer treatment at the AACR 2025 conference. Pfizer CEO Albert Bourla indicated that uncertainty surrounding pharmaceutical tariffs is obstructing $150 million in potential investments in U.S. manufacturing and research and development.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.